Skip to main content
. 2019 Jun 24;177(2):447–455. doi: 10.1007/s10549-019-05326-5

Table 1.

Comparison of patient and tumor characteristics between patients positive for CTCs and ctDNA (≥ 1 CTC/≥ 0.01% MAF) and patients with no CTCs/% MAF

Total (N = 31) CTC negative (N = 23) CTC positive (N = 8) p value Total (N = 20) ctDNA negative (N = 7) ctDNA positive (N = 13) p value
Age (years)
Median (range) 50 (33–74) 47 (33–74) 56 (43–71) 0.21a 51 (35–74) 46 (35–62) 58 (40–74) 0.05a
  < 50 16 13 3 0.43b 10 5 5 0.35b
  ≥ 50 15 10 5 10 2 8
Tumor size and stage
 Median size, mm (range) 30 (4–90) 30 (4–90) 38 (16–80) 0.21a 30 (4–80) 24 (8–80) 30 (4–80) 0.60a
 T1 (< 20 mm) 8 7 1 0.64b 6 3 3 0.61b
 T2–T4 (20 mm or higher) 23 16 7 14 4 10
Nodal stage
 N0 4 3 1 1.0b 2 0 2 0.52b
 N+ 27 20 7 18 7 11
ER
 Negative (10% or lower) 8 6 2 1.0b 4 0 4 0.25b
 Positive (> 10%) 23 17 6 16 7 9
HER2
 Negative 25 18 7 1.0b 17 5 12 0.27b
 Positive 6 5 1 3 2 1
Ki67
 Median % of cells stained (range) 45 (15–95) 45 (20–95) 49 (15–90) 0.61a 40 (15–90) 30 (15–90) 45 (20–90) 0.19a
 Low (20% or lower) 3 2 1 1.0b 3 1 2 1.0b
 High (> 20%) 28 21 7 17 6 11
Breast cancer subtype
 ER+ 18 12 6 0.63b 13 5 8 0.20b
 HER2+ 6 5 1 3 2 1
 TNBC 7 6 1 4 0 4
Multifocality
 No 22 17 5 0.64b 15 4 11 0.29b
 Yes 8 5 3 5 3 2
 Missing 1 1
Histological subtype
 Ductal 23 19 4 0.15b 13 3 10 0.17b
 Other 8 4 4 7 4 3
Detection mode
 Screening 9 7 2 1.0b 8 2 6 0.64b
 Symptomatic 22 16 6 12 5 7

aMann–Whitney U-test

bFisher’s exact test